Clinical Trial Update: A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Participants With HER 2-Negative Aggressive Metastatic Breast Cancer

View source ↗

Summary

A completed clinical trial evaluating predictive and prognostic tools to optimize frontline therapy with bevacizumab in HER2-negative aggressive metastatic brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Status: COMPLETED | Results posted: 2020-01-18